Tuesday, May 13, 2025

Agilisium Achieves AWS Life Sciences Competency Status

Related stories

BigID Launches AI Privacy Console for Risk Management

BigID, a leading innovator in data security, privacy, compliance,...

Zencoder Unveils Zen Agents: Custom AI Platform & Marketplace

Breakthrough Technology Empowers Development Teams to Create, Share, and...

Press Ganey Names Avanish Mishra, Ph.D., President, Life Sciences

Press Ganey, the leading provider of experience measurement, analytics,...

QuantHealth Launches AI Model for Clinical Life Sciences

The Foundation Model, Soon to be Available on AWS...

Tricentis Boosts Toolchain in RISE with SAP for AI Cloud

New capabilities help secure and streamline the journey to...
spot_imgspot_img

Agilisium, a pioneering leader in Data Analytics, Cloud, and Life Science solutions, announced that it has won the coveted AWS Life Sciences Competency status; placing the brand among an exclusive group of 28 Consulting Partners out of 8,300+ AWS Partners globally. This remarkable achievement demonstrates the company’s proven expertise in delivering transformative cloud solutions to pharmaceutical companies, seeking to expedite drug discovery, strengthen clinical trials, and develop novel genetic-based treatments.

Agilisium has developed over 20 GenAI-powered data analytics solutions exemplifying the company’s innovative approach, enabling pharma organizations to unlock deeper insights, and accelerate research and development cycles; thereby bringing life-saving treatments to patients more efficiently. Furthermore, Agilisium’s solutions and accelerators can be accessed through the AWS marketplace.

Also Read: Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

Commenting on the achievement, Mr. Raj Babu, Founder and CEO of Agilisium said, “Earning the AWS Life Sciences Competency status is a significant milestone for Agilisium. This achievement reflects our team’s unwavering dedication to understanding the complex challenges in the pharma industry and developing solutions that effectively address them. By harnessing the power of our GenAI solutions, we are confident that we can usher in a new era of data-driven discovery and innovation in life sciences. Additionally, this recognition would enable our clients to transform data into meaningful insights, ultimately delivering life-changing therapies to patients faster, globally.”

As one of the few AWS-certified Data Analytics partners with specialized expertise in the pharmaceutical industry, Agilisium is uniquely positioned to offer a wide range of AWS services tailored for the Life Sciences industry. This includes generative AI solutions, advanced analytics, data lakes, and machine learning, among several others. The company also offers AWS’ MAP (Migration Acceleration Program) funding program and No-Cost Assessment program for its clients which significantly helps clients to accelerate faster Cloud Transformation journeys.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img